B. Henselae Ab (IgG), Screen

Positive
A positive result in the B. Henselae Ab (IgG) screen holds significant clinical implications, primarily indicating exposure to Bartonella henselae, the bacterium causing Cat Scratch Disease (CSD). This positive outcome suggests that the patient's immune system has produced IgG antibodies in response to either a past or ongoing infection with B. henselae. In the context of a patient presenting with symptoms like fever, swollen lymph nodes, or in more severe cases, manifestations such as bacillary angiomatosis or neuroretinitis, a positive IgG screen supports the diagnosis of CSD or a related Bartonella infection. It's crucial to note, however, that IgG antibodies can persist long after the initial infection has resolved. Consequently, a positive result does not necessarily indicate an active infection but rather shows exposure at some point. The timing of exposure can be difficult to ascertain solely from a positive IgG screen. This makes the clinical correlation essential; the patient's history, symptomatology, and potential exposures, such as contact with cats, are crucial for interpreting the test result accurately. In patients with a compatible clinical picture, a positive B. Henselae IgG test can guide appropriate treatment and management. While a positive B. Henselae IgG screen is a key indicator of exposure to the bacterium, its interpretation requires a careful consideration of the overall clinical context to determine its relevance to the current clinical scenario.

The Bartonella henselae antibody (IgG) screen is a serological test used to detect the presence of IgG antibodies against Bartonella henselae, the bacterium responsible for Cat Scratch Disease (CSD).

This screening test is essential in the diagnostic workup of patients presenting with symptoms suggestive of CSD, such as prolonged fever, lymphadenopathy, and in some cases, more severe complications like bacillary angiomatosis or neuroretinitis. The IgG antibodies typically develop a few weeks after the initial infection and can persist in the body for a long time, potentially indicating either a past or an ongoing infection. The significance of this test lies in its ability to help differentiate CSD from other conditions with similar clinical presentations. A positive result in the B. henselae IgG screen suggests that the patient has been exposed to the bacterium, triggering an immune response. However, the presence of IgG antibodies alone does not definitively confirm active infection, as these antibodies can remain long after the initial exposure, reflecting past infection or immunity. Therefore, in interpreting the results, clinicians must consider the patient's clinical history, symptomatology, and potential exposure to risk factors, such as contact with cats or receiving a cat scratch or bite. The test is particularly useful in epidemiological contexts where Bartonella infections are common, aiding in both individual patient diagnosis and broader public health understanding of the prevalence and impact of the bacterium. In summary, the B. henselae IgG screen is a valuable tool in identifying exposure to Bartonella henselae, but the results should be carefully evaluated in conjunction with clinical findings to make an accurate diagnosis.

B. Henselae Ab (IgG), Screen
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond B. Henselae Ab (IgG), Screen — 10,000+ markers explained
One B. Henselae Ab (IgG), Screen result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro